MyFinsight
Home
About
Contact
dawn: the income statement
Download
Download image
Net loss
-$19,726K
(-153.26%↓ Y/Y)
Investment income, net
$4,559K
(-14.34%↓ Y/Y)
Loss before income
taxes
$19,726K
(154.56%↑ Y/Y)
Total non-operating
income, net
$4,525K
(-30.59%↓ Y/Y)
License
$1,273K
Product
$38,522K
Other expense, net
-$34K
(-102.84%↓ Y/Y)
Loss from operations
-$24,251K
(-181.83%↓ Y/Y)
Total revenues
$39,795K
(-57.56%↓ Y/Y)
Total cost and
operating expenses
$64,046K
(-0.12%↓ Y/Y)
Selling, general and
administrative
$28,147K
(-2.85%↓ Y/Y)
Research and development
$31,419K
(-6.39%↓ Y/Y)
Cost of product and
license revenue
$4,480K
Back
Back
Income Statement
source: myfinsight.com
Day One Biopharmaceuticals, Inc. (DAWN)
Day One Biopharmaceuticals, Inc. (DAWN)